药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rosoxacin
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Bromocriptine.
Rosoxacin
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromocriptine.
Rosoxacin
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Bromocriptine.
Rosoxacin
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Bromocriptine.
Rosoxacin
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Bromocriptine.
Rosoxacin
Dexniguldipine
The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Bromocriptine.
Rosoxacin
Tetrandrine
The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Bromocriptine.
Rosoxacin
Lomerizine
The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Bromocriptine.
Rosoxacin
Emopamil
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Bromocriptine.
Rosoxacin
Dexverapamil
The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Bromocriptine.
Rosoxacin
Gallopamil
The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Bromocriptine.
Rosoxacin
Bepridil
The risk or severity of hypoglycemia can be increased when Bepridil is combined with Bromocriptine.
Rosoxacin
Empagliflozin
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Empagliflozin.
Rosoxacin
Balaglitazone
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Balaglitazone.
Rosoxacin
Ciglitazone
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Ciglitazone.
Rosoxacin
Rivoglitazone
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Rivoglitazone.
Rosoxacin
Netoglitazone
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Netoglitazone.
Rosoxacin
Lobeglitazone
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Lobeglitazone.
Rosoxacin
Alogliptin
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Alogliptin.
Rosoxacin
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Gastric inhibitory polypeptide.